SpringWorks Therapeutics, Inc. - COM (SWTX)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
80.3M
Holdings value Q3 2024
$2.57B
Value change Q3 2024
+$35.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
218
Number of buys Q3 2024
124
Number of sells Q3 2024
-82
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 80.3M $2.57B +$35.7M $32.04 220
2024 Q2 77.1M $2.9B -$72.6M $37.67 204
2024 Q1 77.8M $3.83B +$153M $49.22 212
2023 Q4 74.4M $2.72B +$388M $36.50 175
2023 Q3 67.3M $1.55B -$39.9M $23.12 142
2023 Q2 69.6M $1.82B +$89.5M $26.22 140
2023 Q1 66.2M $1.7B -$5.03M $25.74 145
2022 Q4 66.5M $1.72B +$78.2M $26.01 137
2022 Q3 63.2M $1.8B +$232M $28.53 145
2022 Q2 55.3M $1.36B +$60.4M $24.62 137
2022 Q1 49.4M $2.79B +$223M $56.44 134
2021 Q4 45.4M $2.82B +$26.8M $61.98 141
2021 Q3 45.1M $2.86B +$40.1M $63.44 139
2021 Q2 44.7M $3.69B +$75.2M $82.41 132
2021 Q1 43.9M $3.23B +$39.7M $73.57 134
2020 Q4 43.4M $3.15B +$420M $72.52 122
2020 Q3 37.4M $1.78B +$128M $47.67 91
2020 Q2 34.8M $1.46B +$82.3M $42.00 77
2020 Q1 33M $891M +$24.8M $27.00 68
2019 Q4 31.9M $1.23B +$28.1M $38.49 56
2019 Q3 31.2M $677M +$677M $21.68 43
2019 Q2 53.9K $4.45M $0 $82.41 1
2019 Q1 53.9K $4.45M $0 $82.41 1